Browse
Temperature changes, shifting precipitation patterns, and increasing vector-human contact have led to a wider prevalence of kidney diseases across the world.
ASN supports accelerated manufacturing and distribution of monoclonal antibodies for COVID-19 that provide additional prophylactic benefit to immunocompromised populations.